These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22447046)

  • 1. Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: implications for the role of Zbtb7 in cell cycle regulation.
    Yang X; Zu X; Tang J; Xiong W; Zhang Y; Liu F; Jiang Y
    Mol Med Rep; 2012 Jun; 5(6):1475-80. PubMed ID: 22447046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of protein expression in HepG2 cells with CDK2 RNA interference].
    Shang J; Wang Z; Li J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):359-63. PubMed ID: 23643165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
    Garneau H; Paquin MC; Carrier JC; Rivard N
    J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of down-regulation of Cdk2 activity in hepatocyte growth factor-induced cell cycle arrest at G1 in the human hepatocellular carcinoma cell line HepG2.
    Tsukada Y; Tanaka T; Miyazawa K; Kitamura N
    J Biochem; 2004 Nov; 136(5):701-9. PubMed ID: 15632311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
    Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZBTB7/miR-137 Autoregulatory Circuit Promotes the Progression of Renal Carcinoma.
    Wang L; Li Q; Ye Z; Qiao B
    Oncol Res; 2019 Sep; 27(9):1007-1014. PubMed ID: 29673422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression.
    Calbó J; Parreño M; Sotillo E; Yong T; Mazo A; Garriga J; Grana X
    J Biol Chem; 2002 Dec; 277(52):50263-74. PubMed ID: 12401786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation.
    Sivertsson L; Edebert I; Palmertz MP; Ingelman-Sundberg M; Neve EP
    Mol Pharmacol; 2013 Mar; 83(3):659-70. PubMed ID: 23264496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.
    Park AM; Tsunoda I; Yoshie O
    J Biol Chem; 2018 Oct; 293(41):15815-15826. PubMed ID: 30166342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9.
    Ma Z; Li Q; Wang W; Deng Z
    Int J Oncol; 2024 Oct; 65(4):. PubMed ID: 39239750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle-related transformation of the E2F4-p130 repressor complex.
    Popov B; Chang LS; Serikov V
    Biochem Biophys Res Commun; 2005 Oct; 336(3):762-9. PubMed ID: 16153605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
    Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
    Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
    Zhao H; Zhang Y; Sun J; Zhan C; Zhao L
    Oncol Res; 2016; 23(5):237-48. PubMed ID: 27098147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S; Kasamatsu A; Yamatoji M; Nakashima D; Endo-Sakamoto Y; Koide N; Takahara T; Shimizu T; Iyoda M; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 486(2):385-390. PubMed ID: 28315328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
    Carroll JS; Prall OW; Musgrove EA; Sutherland RL
    J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
    Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
    Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.